It depends on the standard you follow. As of September 2026, Apyx Medical Corporation (APYX) passes 3 of 5 published Shariah screening standards checked by Maz Vantage: it passes AAOIFI, S&P Global and Dow Jones, and fails MSCI and FTSE.
| Standard | Ratios (value / limit) | Result |
|---|---|---|
| AAOIFI | Debt / Mkt Cap (36m) 29.9% / 30% · (Cash+Inv) / Mkt Cap (36m) 21.7% / 30% · Interest income / Revenue 2.04% / 5% | Pass |
| S&P Global | Debt / Mkt Cap (36m) 29.9% / 33% · (Cash+ST Inv) / Mkt Cap (36m) 21.7% / 33% · Receivables / Mkt Cap (36m) 12.5% / 49% · Interest income / Revenue 2.04% / 5% | Pass |
| Dow Jones | Debt / Mkt Cap (24m) 29.9% / 33.33% · (Cash+ST Inv) / Mkt Cap (24m) 21.7% / 33.33% · Receivables / Mkt Cap (24m) 12.5% / 33.33% · Interest income / Revenue 2.04% / 5% | Pass |
| MSCI | Debt / Avg Assets (4Q) 55.9% / 33.33% · (Cash+ST Inv) / Avg Assets (4Q) 46.0% / 33.33% · Receivables / Avg Assets (4Q) 23.0% / 33.33% · Interest income / Revenue 2.04% / 5% | Fail |
| FTSE | Debt / Total Assets 57.7% / 33.33% · (Cash+ST Inv) / Total Assets 41.8% / 33.33% · (Cash+Recv) / Total Assets 65.9% / 33.33% · Interest income / Revenue 2.04% / 5% | Fail |
It depends on the standard you follow. As of September 2026, Apyx Medical Corporation (APYX) passes 3 of 5 published Shariah screening standards checked by Maz Vantage: it passes AAOIFI, S&P Global and Dow Jones, and fails MSCI and FTSE.
Yes. Apyx Medical Corporation is within every AAOIFI limit: debt and interest-bearing cash and investments under 30% of its 36-month average market cap, and interest income under 5% of revenue.
About 2.04% of each dividend: Apyx Medical Corporation's interest income as a share of its revenue. Give that share to charity; the dividend purification calculator works it out per holding.
The screen is rerun on each quarterly report; the figures here are from the balance sheet dated September 30, 2026 (Q3 2026). A status can change from one quarter to the next as debt, cash and market value move.
See also the list of halal stocks, halal healthcare stocks, the halal stock screener, the dividend purification calculator and the zakat calculator.
A mechanical screen of published financial ratios and the company's line of business, not a religious ruling. It does not test every revenue stream; check with a scholar you trust.
Apyx Medical Corporation (NASDAQ: APYX) is a Healthcare company (Medical - Specialties) with a market capitalization of $108M. The Maz Rating grades it against the other companies in its sector.
Apyx Medical Corporation's current Maz Rating and its five factor grades are for members: log in to see them.
At $2.56, Apyx Medical Corporation trades at 1.7x sales and 11.1x book value. Over the last twelve months it generated about $63M of revenue and a net loss of $9M. It runs a gross margin of 34.5%, an operating margin of -5.5% and a net margin of -14.2%. It shows return on equity of -70.8%, return on invested capital of -6.4% and a free cash flow yield of -8.4%. On the balance sheet: a debt-to-equity ratio of 4.13 and a current ratio of 4.95. Over the past 52 weeks the share price ranged from $2.25 to $5.08, with a beta of 1.31.
Apyx Medical Corporation does not currently pay a dividend.
9 Wall Street analyst ratings cover the stock: 8 Buy and 1 Hold, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures; and a portfolio of single-use handpieces and accessories for open and laparoscopic procedures. The company’s helium plasma technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures OEM generators and related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.